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n Regulation of N-cadherin-
mediated adhesion by the
p35–Cdk5 kinase.
Young T Kwon, Amitabh Gupta,
Ying Zhou, Margareta Nikolic and
Li-Huei Tsai (2000). Curr. Biol.
10, 363–372.
The p35–Cdk5 kinase has been
implicated in a variety of functions in the
central nervous system, including axon
outgrowth, axon guidance, and neuronal
migration during cortical development.
In p35–/– mice, embryonic cortical
neurons are unable to migrate past their
predecessors, leading to an inversion of
cortical layers in the adult cortex. The
authors identify molecules important for
p35–Cdk5-dependent function in the
cortex, by screening for p35-interacting
proteins using the two-hybrid system.
They identify a novel interaction
between p35 and the versatile cell
adhesion signaling molecule β-catenin.
The association between p35–Cdk5 and
an N-cadherin adhesion complex in
cortical neurons and the modulation of
N-cadherin-mediated aggregation by
p35–Cdk5 suggest that the p35–Cdk5
kinase is involved in the regulation of
N-cadherin-mediated adhesion in
cortical neurons.
16 March 2000, Research Paper,
Current Biology.
n Conformational rearrangements
of an archaeal chaperonin upon
ATPase cycling.
Irina Gutsche, Jörg Holzinger, Manfred
Rößle, Hermann Heumann, Wolfgang
Baumeister and Roland P May
(2000). Curr. Biol. 10, 405–408.
Chaperonins are double-ring protein
assemblies with a central cavity that
provides a sequestered environment for
in vivo protein folding. The reaction
cycle is thought to consist of a
nucleotide-regulated alternation
between an open substrate-acceptor
state and a closed folding-active state.
The cavity of ATP-charged group I
chaperonins, such as Escherichia coli
GroEL, is sealed off by a co-chaperonin,
whereas group II chaperonins, such as
the archaeal thermosome and
eukaryotic TRiC/CCT, have a built-in
lid. Here, the conformation of the
thermosome is analyzed at each step of
the ATPase cycle, using small-angle
neutron scattering. The apo-chaperonin
is open in solution, and ATP binding
induces its further expansion. Closure
apparently occurs during ATP
hydrolysis, and represents the rate-
limiting step of the cycle. The allosteric
regulation of group II chaperonins
appears different from that of group I
chaperonins.
24 March 2000, Brief Communication,
Current Biology. 
n Assembly of an A kinase-
anchoring protein–β2-adrenergic
receptor complex facilitates
receptor phosphorylation
and signaling.
Iain DC Fraser, Mei Cong, Jihee Kim,
Emily N Rollins, Yehia Daaka, Robert
J Lefkowitz and John D Scott
(2000). Curr. Biol. 10, 409–412.
Phosphorylation of G-protein-
coupled receptors by second-
messenger-stimulated kinases is
essential in the process of receptor
desensitization. Phosphorylation of the
β2-adrenergic receptor (β2-AR) by
protein kinase A (PKA), in addition to
uncoupling adenylate cyclase
activation, is obligatory for receptor-
mediated activation of mitogen-
activated protein kinase (MAP kinase)
cascades. Although mechanisms for
linking G-protein-coupled receptor
kinases to the activated receptor are
well established, analogous
mechanisms for targeting second
messenger kinases to β2-AR at the
plasma membrane have not been
elucidated. Functional studies show
that PKA anchoring is required to
enhance β2-AR phosphorylation and to
facilitate downstream activation of the
MAP kinase pathway. This defines a
role for the A-kinase-anchoring protein
AKAP79/150 in the recruitment of
second-messenger-regulated signaling
enzymes to a G-protein-coupled
receptor.
24 March 2000, Brief Communication,
Current Biology. 
n Nitric oxide interacts with the
retinoblastoma pathway to
control eye development in
Drosophila.
Boris Kuzin, Michael Regulski, Yuri
Stasiv, Vladimir Scheinker, Tim Tully
and Grigori Enikolopov (2000). Curr.
Biol. 10, 459–462.
Animal organ development requires
that tissue patterning and
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differentiation is tightly coordinated
with cell multiplication and cell-cycle
progression. In imaginal discs of
developing Drosophila larvae, cell-
cycle progression is controlled by a
modified version of the well-
characterized mammalian
retinoblastoma (Rb) pathway, which
integrates signals from multiple
effectors ranging from growth factors
and receptors to small signaling
molecules. Nitric oxide, a multi-
functional second messenger, can
reversibly suppress DNA synthesis
and cell division. In developing flies,
the antiproliferative action of nitric
oxide is essential for regulating the
balance between cell proliferation and
differentiation. The mechanisms of
the antiproliferative activity of nitric
oxide in developing organisms are not
known, however, and the authors
address this. Manipulation of
endogenous or transgenic nitric oxide
synthase activity during imaginal disc
development can enhance or suppress
the effects of the Rb-like protein RBF
and the transcription factor E2F on
development of the eye. The results
suggest a role for nitric oxide in the
developing imaginal eye disc through
interaction with the Rb pathway.
7 April 2000, Brief Communication,
Current Biology. 
n Active demethylation of the
paternal genome in the mouse
zygote.
J Oswald, S Engemann, N Lane, W
Mayer, A Olek, R Fundele, W Dean,
W Reik and J Walter (2000). Curr.
Biol. 10, 475–478.
DNA methylation is essential for the
control of many biological mechanisms
in mammals. Mammalian development
is accompanied by two major waves of
genome-wide demethylation and
remethylation: one during germ-cell
development and the other after
fertilisation. Most studies have
suggested that the genome-wide
demethylation observed after
fertilisation occurs passively, by the lack
of maintenance methylation following
DNA replication and cell division,
although one study has reported that
replication-independent demethylation
might also occur during early
embryogenesis. The authors report that
genes that are highly methylated in
sperm are rapidly demethylated in the
zygote only hours after fertilisation,
before the first round of DNA
replication commences. By contrast, the
oocyte-derived maternal alleles are
unaffected by this reprogramming.
Whereas paternally derived sequences
are exposed to putative active
demethylases in the oocyte cytoplasm,
maternally derived sequences are
protected from this reaction. These
results have important implications for
the establishment of biparental genetic
totipotency after fertilisation, the
establishment and maintenance of
genomic imprinting, and the
reprogramming of somatic cells
during cloning.
7 April 2000, Brief Communication,
Current Biology. 
n Stimulation of V(D)J
recombination by histone
acetylation.
Fraser McBlane and Joan Boyes
(2000). Curr. Biol. 10, 483–486.
V(D)J recombination assembles
functional immunoglobulin and T cell
receptor genes from individual gene
segments. A common recombination
mechanism, initiated by the proteins
RAG1 and RAG2 at conserved
recombination signal sequences (RSSs),
operates at all rearranging loci. It has
been proposed that the key regulator of
the reaction is ‘accessibility’ of the RSS
within chromatin. Recently, the
packaging of RSSs into nucleosomes
was shown to inhibit initiation of V(D)J
recombination. Nevertheless, the tight
tissue specificity of regulation cannot be
explained by nucleosome-mediated
repression alone because a significant
fraction of RSSs would be predicted to
lie in linker regions between
nucleosomes. Some aspect of the
regulation of the recombination reaction
must therefore rely on the disruption of
higher-order chromatin structure.
Histone acetylation directly stimulates
the recombination reaction in vivo in the
correct cell- and stage-specific manner.
Neither expression of RAG genes nor
activity of RAG proteins was increased
by acetylation. Histone acetylation
failed to overcome nucleosome-
mediated repression of RSS recognition
and cleavage in vitro. The data suggest a
role for histone acetylation in
stimulating recombination in vivo
through disruption of higher-order
chromatin structures.
7 April 2000, Brief Communication,
Current Biology. 
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n Cell cycle restriction of telomere
elongation.
Stéphane Marcand, Vanessa Brevet,
Carl Mann and Eric Gilson (2000).
Curr. Biol. 10, 487–490.
Telomere elongation by telomerase
balances the progressive shortening of
chromosome ends resulting from the
succession of replication cycles.
Telomerase activity is regulated in vivo
at its site of action by the telomere
itself. In yeast and human cells, the
mean telomere length is maintained at a
constant value through a cis-inhibition of
telomerase by factors specifically bound
to the telomeric DNA. The authors test
the link between telomere dynamics
and cell-cycle progression in the
budding yeast Saccharomyces cerevisiae.
They observed that telomere elongation
is linked to the succession of cell
divisions. In cells progressing
synchronously through the cell cycle,
telomere elongation coincided with the
time of telomere replication. On a
minichromosome, a replication defect
partially suppressed telomere
elongation, suggesting a coupling
between in vivo telomerase activity and
conventional DNA replication.
7 April 2000, Brief Communication,
Current Biology. 
n Enzymes of vancomycin
resistance: the structure of
D-alanine–D-lactate ligase of
naturally resistant Leuconostoc
mesenteroides.
Alexandre P Kuzin, Tao Sun,
Jodi Jorczak-Baillass, Vicki L Healy,
Christopher T Walsh and James R
Knox (2000). Structure 8, 463–470.
The bacterial cell wall and the enzymes
that synthesize it are targets of
glycopeptide antibiotics (vancomycins
and teicoplanins) and β-lactams
(penicillins and cephalosporins).
Biosynthesis of cell-wall peptidoglycan
requires a cross-linking of peptidyl
moieties on adjacent glycan strands. The
D-alanine–D-alanine transpeptidase,
which catalyzes this cross-linking, is the
target of β-lactam antibiotics.
Glycopeptides do not inhibit an enzyme,
but bind directly to D-alanine–D-alanine
and prevent subsequent cross-linking by
the transpeptidase. Resistance to
vancomycin in enterococcal pathogens
has been traced to altered ligases
producing D-alanine–D-lactate rather than
D-alanine–D-alanine. The structure of a
D-alanine–D-lactate ligase has been
determined.  Comparison of this
D-alanine–D-lactate ligase with the
known structure of DdlB D-alanine–
D-alanine ligase, a wild-type enzyme that
does not provide vancomycin resistance,
reveals alterations in the size and
hydrophobicity of the site for D-lactate
binding (subsite 2). Structural differences
at subsite 2 of the D-alanine–D-lactate
ligase help explain a substrate specificity
shift (D-alanine to D-lactate) leading to
remodeled cell wall peptidoglycan and
vancomycin resistance in gram-positive
pathogens.
18 April 2000, Research Paper, Structure. 
n The structure of the N-terminal
actin-binding domain of human
dystrophin and how mutations in
this domain may cause Duchenne
or Becker muscular dystrophy.
Fiona LM Norwood, Andrew J
Sutherland-Smith, Nicholas H Keep
and John Kendrick-Jones (2000).
Structure 8, 481–492.
Dystrophin is a large multidomain
protein component of skeletal muscle
cells. Its amino-terminal domain binds to
F-actin and its carboxyl terminus binds
to the dystrophin-associated
glycoprotein complex in the membrane.
Dystrophin is thought to serve as a link
from the actin-based cytoskeleton of the
muscle cell through the plasma
membrane to the extracellular matrix.
Pathogenic mutations in dystrophin
result in Duchenne or Becker muscular
dystrophy. The crystal structure of the
dystrophin actin-binding domain (ABD)
has been determined. The structure is
an antiparallel dimer of two ABDs, each
comprising two calponin homology (CH)
domains that are linked by a central α
helix. The dystrophin ABD structure
reveals a previously uncharacterised
arrangement of the CH domains within
the ABD. This observation has
implications for the mechanism of actin
binding by dystrophin and related
proteins. Examining the position of
three pathogenic missense mutations
within the structure suggests that they
exert their effects through misfolding of
the ABD, rather than through disruption
of the binding to F-actin.
25 April 2000, Research Paper, Structure.
n The crystal structure of the
conserved GTPase of SRP54
from the archaeon Acidianus
ambivalens and its comparison
with related structures suggests
a model for the SRP–SRP
receptor complex.
Guillermo Montoya, Kai te Kaat,
Ralph Moll, Günter Schäfer and
Irmgard Sinning (2000). Structure
8, 515–526.
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Protein targeting to the endoplasmic
reticulum in eukaryotes and to the cell
membrane in prokaryotes is mediated by
the signal recognition particle (SRP) and
its receptor (SR). Both contain conserved
GTPase domains in the signal-peptide-
binding proteins (SRP54 and Ffh) and
the SR proteins (SRα and FtsY). These
GTPases are involved in the regulation of
protein targeting. Most studies have
focused on the SRP machinery of
mammals and bacteria, leaving the SRP
system of archaea less well understood.
The crystal structure of the conserved
GTPase (NG-Ffh) from the thermophilic
archaeon Acidianus ambivalens and of the
Thr112→Ala mutant, which is inactive in
GTP hydrolysis, has been determined. It
allows a detailed comparison with related
structures from Escherichia coli and
thermophilic bacteria. In particular,
differences in the conserved consensus
regions for nucleotide binding and the
subdomain interfaces are observed, which
provide information about the regulation
of the GTPase. The overall structure of
SRP-GTPases is well conserved between
bacteria and archaea, which indicates
strong similarities in the regulation of the
SRP-targeting pathway. Surprisingly,
structure comparisons identified a
homodimeric ATP-binding protein as the
closest relative. A heterodimer model for
the SRP–SR interaction is presented.
2 May 2000, Research Paper, Structure. 
n Crystal structure of the Ffh and
EF-G binding sites in the
conserved domain IV of
Escherichia coli 4.5S RNA.
Luca Jovine, Tobias Hainzl, Chris
Oubridge, William G Scott, Jade Li,
Titia K Sixma, Alan Wonacott,
Tadeusz Skarzynski and Kiyoshi
Nagai (2000). Structure 8, 527–540.
Bacterial signal recognition particle
(SRP), consisting of 4.5S RNA and Ffh
protein, plays an essential role in
targeting signal-peptide-containing
proteins to the secretory apparatus in
the cell membrane. The 4.5S RNA
increases the affinity of Ffh for signal
peptides and is essential for the
interaction between SRP and its
receptor, protein FtsY. The 4.5S RNA
also interacts with elongation factor G
(EF-G) in the ribosome and this
interaction is required for efficient
translation. The crystal structure of a
4.5S RNA fragment containing binding
sites for both Ffh and EF-G has been
determined. The structure can be
regarded as two double helical rods
hinged by the asymmetric loop that
protrudes from one strand. The
decanucleotide structure in the 4.5S
RNA and the ribosomal protein
L11–RNA complex crystals suggests
how 4.5S RNA and 23S rRNA might
interact with EF-G and function in
translating ribosomes.
2 May 2000, Research Paper, Structure.
n A potential target enzyme for
trypanocidal drugs revealed by
the crystal structure of NAD-
dependent glycerol-3-phosphate
dehydrogenase from
Leishmania mexicana.
Stephen Suresh, Stewart Turley,
Fred R Opperdoes, Paul AM
Michels and Wim GJ Hol (2000).
Structure 8, 541–552.
NAD-dependent glycerol-3-phosphate
dehydrogenase (GPDH) catalyzes the
interconversion of dihydroxyacetone
phosphate and l-glycerol-3-phosphate.
The enzyme has been characterized and
cloned from a number of sources, but no
three-dimensional structure has been
determined for this enzyme. Although
the use of this enzyme as a drug target
against Leishmania mexicana is yet to be
established, the critical role played by
GPDH in the long slender bloodstream
form of the related kinetoplastid
Trypanosoma brucei makes it a viable
drug target against sleeping sickness.
The crystal structure of apo GPDH
from L. mexicana was determined and
used to solve the holo structure in
complex with NADH. It is the first
structure of this enzyme from any
source and, in view of the sequence
identity of 63%, is a valid model for the
T. brucei enzyme. The differences
between the human and trypanosomal
enzymes are extensive, with only 29%
sequence identity between the parasite
and host enzyme, and support the
feasibility of exploiting the NADH-
binding site to develop selective
inhibitors against trypanosomal GPDH.
The structure also offers a plausible
explanation for the inhibition of the
T. brucei enzyme by melarsen oxide, the
active form of the trypanocidal drugs
melarsoprol and cymelarsan.
3 May 2000, Research Paper, Structure.
n Structure-directed discovery of
potent non-peptidic inhibitors of
human urokinase that access a
novel binding subsite.
Vicki L Nienaber, Donald Davidson,
Rohinton Edalji, Vincent L Giranda,
Vered Klinghofer, Jack Henkin, Peter
Magdalinos, Robert Mantei, Sean
Merrick, Jean M Severin, Richard A
Smith, Kent Stewart, Karl Walter,
Jieyi Wang, Michael Wendt, Moshe
Weitzberg, Xumiao Zhao and Todd
Rockway (2000). Structure
8, 553–563.
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Human urokinase-type plasminogen
activator has been implicated in the
regulation and control of basement
membrane and interstitial protein
degradation. Because of its role in tissue
remodeling, urokinase is a central player
in the disease progression of cancer,
making it an attractive target for the
design of an anticancer clinical agent.
Few urokinase inhibitors have been
described, which suggests that discovery
of such a compound is in the early stages.
A new human urokinase crystal form
amenable to structure-based drug design
has been used to discover potent
urokinase inhibitors. On the basis of
crystallographic data, 2-naphthamidine
was chosen as the lead scaffold for
structure-directed optimization. This co-
crystal structure shows the compound
binding at the primary specificity pocket
of the trypsin-like protease and at a
novel binding subsite accessible from
the 8-position of 2-napthamidine. This
novel subsite was characterized and used
to design two compounds with very
different 8-substituents that inhibit
urokinase with Ki values of 30–40 nM.
Utilization of a novel subsite yielded two
potent urokinase inhibitors even though
this site has not been widely used in
inhibitor optimization with other trypsin-
like proteases, such as those reported for
thrombin or factor Xa. The extensive
binding pockets present at the substrate-
binding groove of these other proteins
are blocked by unique insertion loops in
urokinase, thus necessitating the
utilization of additional binding subsites.
Successful implementation of this
strategy and characterization of the novel
site provides a significant step towards
the discovery of an anticancer agent.
3 May 2000, Research Paper, Structure.
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